|
|
Article: Hoffman-La Roche to meet with FDA concerning Accutane.
- Article from:
- PR Newswire
- Article date:
- April 27, 1988
CopyrightCOPYRIGHT 1988 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HOFFMAN-LA ROCHE TO MEET WITH FDA CONCERNING ACCUTANE
WASHINGTON, April 26 /PRNewswire/ -- Hoffman-La Roche said today that it would move promptly to meet with the Food and Drug Administration (FDA) to implement several new innovative programs to re-emphasize long-standing warnings that Accutane (isotretinoin/ Roche) not be used by females who are pregnant or who intend to become pregnant while undergoing treatment.
In addition the company said it will pursue with the FDA other options to reinforce the appropriate use of Accutane, a drug prescribed for the treatment of severe recalcitrant cystic acne.
Roche announced its commitment to ...